230 related articles for article (PubMed ID: 34226953)
1. High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics.
Kesch C; Yirga L; Dendl K; Handke A; Darr C; Krafft U; Radtke JP; Tschirdewahn S; Szarvas T; Fazli L; Gleave M; Giesel FL; Haberkorn U; Hadaschik B
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):385-389. PubMed ID: 34226953
[TBL] [Abstract][Full Text] [Related]
2.
Li C; Chen Q; Tian Y; Chen J; Xu K; Xiao Z; Zhong J; Wu J; Wen B; He Y
J Nucl Med; 2024 Apr; 65(4):527-532. PubMed ID: 38453362
[TBL] [Abstract][Full Text] [Related]
3.
Lanzafame H; Mavroeidi IA; Pabst KM; Desaulniers M; Ingenwerth M; Hirmas N; Kessler L; Nader M; Bartel T; Leyser S; Barbato F; Schuler M; Bauer S; Siveke JT; Herrmann K; Hamacher R; Fendler WP
J Nucl Med; 2024 Jun; 65(6):880-887. PubMed ID: 38724279
[TBL] [Abstract][Full Text] [Related]
4. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
[TBL] [Abstract][Full Text] [Related]
5. Correlation of
Mona CE; Benz MR; Hikmat F; Grogan TR; Lueckerath K; Razmaria A; Riahi R; Slavik R; Girgis MD; Carlucci G; Kelly KA; French SW; Czernin J; Dawson DW; Calais J
J Nucl Med; 2022 Jul; 63(7):1021-1026. PubMed ID: 34740953
[TBL] [Abstract][Full Text] [Related]
6.
Kessler L; Hirmas N; Pabst KM; Hamacher R; Ferdinandus J; Schaarschmidt BM; Milosevic A; Nader M; Umutlu L; Uhl W; Reinacher-Schick A; Lugnier C; Witte D; Niedergethmann M; Herrmann K; Fendler WP; Siveke JT
J Nucl Med; 2023 Dec; 64(12):1910-1917. PubMed ID: 37973185
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of
Chen X; Wang S; Lai Y; Wang G; Wei M; Jin X; Ding J; Zhang Y; Shi Y; Wang F; Zhu H; Yang Z; Wang X
J Nucl Med; 2023 Sep; 64(9):1399-1405. PubMed ID: 37385675
[TBL] [Abstract][Full Text] [Related]
8. Detecting Fibroblast Activation Proteins in Lymphoma Using
Jin X; Wei M; Wang S; Wang G; Lai Y; Shi Y; Zhang Y; Yang Z; Wang X
J Nucl Med; 2022 Feb; 63(2):212-217. PubMed ID: 34049984
[TBL] [Abstract][Full Text] [Related]
9. A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy.
Yang T; Peng L; Qiu J; He X; Zhang D; Wu R; Liu J; Zhang X; Zha Z
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2331-2341. PubMed ID: 36864362
[TBL] [Abstract][Full Text] [Related]
10. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
11. Impact of
Röhrich M; Naumann P; Giesel FL; Choyke PL; Staudinger F; Wefers A; Liew DP; Kratochwil C; Rathke H; Liermann J; Herfarth K; Jäger D; Debus J; Haberkorn U; Lang M; Koerber SA
J Nucl Med; 2021 Jun; 62(6):779-786. PubMed ID: 33097632
[TBL] [Abstract][Full Text] [Related]
12. Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a
Varasteh Z; Mohanta S; Robu S; Braeuer M; Li Y; Omidvari N; Topping G; Sun T; Nekolla SG; Richter A; Weber C; Habenicht A; Haberkorn UA; Weber WA
J Nucl Med; 2019 Dec; 60(12):1743-1749. PubMed ID: 31405922
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical FAP Expression Reflects
Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
[TBL] [Abstract][Full Text] [Related]
14. Improved cancer detection in Waldeyer's tonsillar ring by
Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
[TBL] [Abstract][Full Text] [Related]
15.
Röhrich M; Syed M; Liew DP; Giesel FL; Liermann J; Choyke PL; Wefers AK; Ritz T; Szymbara M; Schillings L; Heger U; Rathke H; Kratochwil C; Huber PE; von Deimling A; Debus J; Kauczor HU; Haberkorn U; Adeberg S
Radiother Oncol; 2021 Jul; 160():192-201. PubMed ID: 33940087
[TBL] [Abstract][Full Text] [Related]
16.
Song W; Zhang X; He S; Gai Y; Qin C; Hu F; Wang Y; Wang Z; Bai P; Wang J; Lan X
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):475-485. PubMed ID: 36269382
[TBL] [Abstract][Full Text] [Related]
17. Head-to-Head Comparison of [
Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of
Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H
J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528
[TBL] [Abstract][Full Text] [Related]
19. 68 Ga-FAPI-46 PET/CT in a Metastatic Castration-Resistant Prostate Cancer Patient With Low PSMA Expression.
Aryana K; Manafi-Farid R; Amini H; Divband G; Moghadam SZ
Clin Nucl Med; 2022 Nov; 47(11):972-973. PubMed ID: 35777753
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of preoperative [
Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]